HSP90AA1 and tuberculosis: Although the IC50 values of TB are relatively high compared to classical HSP90 inhibitors, the compound’s ability to bind HSP90 (Kd = 3.10 μM) and regulate downstream target-related signaling pathways supports its target-specific mode of action.